This year, metadata development is one of our key priorities and we’re making a start with the release of version 5.4.0 of our input schema with some long-awaited changes. This is the first in what will be a series of metadata schema updates.
What is in this update?
Publication typing for citations
This is fairly simple; we’ve added a ‘type’ attribute to the citations members supply. This means you can identify a journal article citation as a journal article, but more importantly, you can identify a dataset, software, blog post, or other citation that may not have an identifier assigned to it. This makes it easier for the many thousands of metadata users to connect these citations to identifiers. We know many publishers, particularly journal publishers, do collect this information already and will consider making this change to deposit citation types with their records.
Every year we release metadata for the full corpus of records registered with us, which can be downloaded for free in a single compressed file. This is one way in which we fulfil our mission to make metadata freely and widely available. By including the metadata of over 165 million research outputs from over 20,000 members worldwide and making them available in a standard format, we streamline access to metadata about scholarly objects such as journal articles, books, conference papers, preprints, research grants, standards, datasets, reports, blogs, and more.
Today, we’re delighted to let you know that Crossref members can now use ROR IDs to identify funders in any place where you currently use Funder IDs in your metadata. Funder IDs remain available, but this change allows publishers, service providers, and funders to streamline workflows and introduce efficiencies by using a single open identifier for both researcher affiliations and funding organizations.
As you probably know, the Research Organization Registry (ROR) is a global, community-led, carefully curated registry of open persistent identifiers for research organisations, including funding organisations. It’s a joint initiative led by the California Digital Library, Datacite and Crossref launched in 2019 that fulfills the long-standing need for an open organisation identifier.
We began our Global Equitable Membership (GEM) Program to provide greater membership equitability and accessibility to organizations in the world’s least economically advantaged countries. Eligibility for the program is based on a member’s country; our list of countries is predominantly based on the International Development Association (IDA). Eligible members pay no membership or content registration fees. The list undergoes periodic reviews, as countries may be added or removed over time as economic situations change.
We will shortly be adding a new feature to Crossmark. In a section called “Clinical Trials” we will be using new metadata fields to link together all of the publications we know about that reference a particular clinical trial.
Most medical journals make clinical trial registration a prerequisite for publication. Trials should be registered with one of the fifteen WHO-approved public trial registries , or with clinicaltrials.gov which is run by the US National Library of Medicine. Once registered, a trial is assigned a clinical trial number (CTN) which is subsequently used to identify that trial in any publications that report on it.
Publications that result from any one trial are likely to be released in multiple journals from different publishers and at different times, for example secondary
analyses coming some time after the publication of the initial results. Cross-publisher collaboration is paramount to linking all of these publications together so that researchers, funders, and regulatory agencies can understand the whole set of results from clinical trials. With this in mind, a group of medical publishers, led by BioMedCentral, approached Crossref to establish a working group, and here, they designed an approach to address this problem: “thread” all the various documents together surrounding a clinical trial.
Updated upstream
To implement threaded publications, publishers extract clinical trial numbers from papers, or ask authors to submit those numbers to them. Publishers add the CTNs to the Crossref DOI metadata via three new fields: clinical trial number, clinical trial registry where trial is registered, and trial stage (pre-results, results or post-results of the trial). Crossref has assigned unique IDs to each trial registry (much the same as we have done for funders in our Funder Registry and for the same reason - trial registry names and URIs can change over time and we need a persistent identifier). Using a combination of trial registry ID and clinical trial number, we can easily identify other content in the Crossref database that cites the same trial. Finally, Crossref displays the clinical trial metadata on the respective papers for all participating Crossmark publishers. Crossmark is a convenient place for readers to access the clinical trial information and is readily accessible directly from the journal article (online and PDF versions). And of course all of the data also goes into our open API so that anyone can make use of it.
The reporting of clinical trial results is notoriously inconsistent, something that the AllTrials initiative is also seeking to address. Publishers can help by collecting this information upstream and disseminating it using the existing Crossref infrastructure.
We ask all publishers to deposit the clinical trial data which is so critical to transparency in this area of research, and have already had the first data in from Crossref member the National Institute of Health Research. Once we launch the initial set of linked clinical trials, we will expand coverage of the threaded publications to include all content that reports on or references a clinical trial, from protocol to results to supporting data and systematic reviews.
Stay tuned and watch this space as threaded publications rolls out to journal articles across publishers!
